Atherosclerotic cardiovascular disease (CVD) is a chronic disorder developing insidiously
throughout life and usually progressing to an advanced stage by the time symptoms occur. It …

The recommendations listed in this document are, whenever possible, evidence based. The
current document constitutes a full revision and includes an extensive evidence review …

In the summer of 2015, the Task Force convened the writing committee to begin the process
of revising the existing set of performance measures for adult patients hospitalized with ST …

Interventions. Copies: This document is available on the World Wide Web sites of the
American College of Cardiology (www. cardiosource. org), the American Heart Association …

Advances in antithrombotic therapy, along with an early invasive strategy, have reduced the
incidence of recurrent ischemic events and death in patients with acute coronary syndromes …

(ACCF) guidelines on secondary prevention, 1 important evidence from clinical trials has
emerged that further supports and broadens the merits of intensive risk-reduction therapies …

Background Despite the importance of ST-segment elevation myocardial infarction (STEMI)
in China, no nationally representative studies have characterised the clinical profiles …

Background Ticagrelor is an oral, reversible, direct-acting inhibitor of the adenosine
diphosphate receptor P2Y12 that has a more rapid onset and more pronounced platelet …

The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

Coronary heart disease (CHD) is the single largest cause of death in the developed
countries and is one of the leading causes of disease burden in developing countries. In …